{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:23:14Z","timestamp":1790619794731,"version":"4.1.0"},"reference-count":33,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,2,21]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>This report describes a multidisciplinary study characterizing the largest series of cyclin D1\u2212 MCL patients. CCND2 translocations are the most frequent genetic event (55%) in cyclin D1\u2212 MCL.<\/jats:p>","DOI":"10.1182\/blood-2012-08-452284","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T06:05:15Z","timestamp":1355983515000},"page":"1394-1402","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":172,"title":["CCND2 rearrangements are the most frequent genetic events in cyclin D1\u2212 mantle cell lymphoma"],"prefix":"10.1182","volume":"121","author":[{"given":"Itziar","family":"Salaverria","sequence":"first","affiliation":[{"name":"Department of Pathology, Hematopathology Unit, Hospital Cl\u00ednic, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona, Spain;"},{"name":"Institute of Human Genetics, University Hospital Schleswig-Holstein Campus Kiel\/Christian-Albrechts University, Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Royo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hematopathology Unit, Hospital Cl\u00ednic, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Carvajal-Cuenca","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hematopathology Unit, Hospital Cl\u00ednic, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillem","family":"Clot","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hematopathology Unit, Hospital Cl\u00ednic, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Navarro","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hematopathology Unit, Hospital Cl\u00ednic, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Valera","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hematopathology Unit, Hospital Cl\u00ednic, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Y.","family":"Song","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Woroniecka","sequence":"additional","affiliation":[{"name":"Cytogenetic Laboratory, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Rymkiewicz","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Maria Sk\u0142odowska-Curie Memorial Institute and Oncology Centre, Warsaw, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Klapper","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hematopathology Section and Lymph Node Registry, Christian Albrechts University, Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena M.","family":"Hartmann","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of W\u00fcrzburg, W\u00fcrzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Sujobert","sequence":"additional","affiliation":[{"name":"Henri Mondor Hospital, Creteil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Wlodarska","sequence":"additional","affiliation":[{"name":"Center for Human Genetics, KU Leuven, Leuven, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Ferry","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gaulard","sequence":"additional","affiliation":[{"name":"Henri Mondor Hospital, Creteil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of W\u00fcrzburg, W\u00fcrzburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Lopez-Guillermo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hematopathology Unit, Hospital Cl\u00ednic, Barcelona, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Quintanilla-Martinez","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Eberhard-Karls-University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Harris","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, University Hospital Schleswig-Holstein Campus Kiel\/Christian-Albrechts University, Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Campo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hematopathology Unit, Hospital Cl\u00ednic, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Be\u00e0","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hematopathology Unit, Hospital Cl\u00ednic, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"10","key":"2019111907353724200_B1","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc2230","article-title":"Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics.","volume":"7","author":"Jares","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2019111907353724200_B2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.semcancer.2011.09.007","article-title":"The complex landscape of genetic alterations in mantle cell lymphoma.","volume":"21","author":"Royo","year":"2011","journal-title":"Semin Cancer Biol"},{"issue":"13","key":"2019111907353724200_B3","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","article-title":"Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling.","volume":"106","author":"Fu","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2019111907353724200_B4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood-2006-01-0015","article-title":"A chromosomal translocation in cyclin D1-negative\/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus.","volume":"108","author":"Gesk","year":"2006","journal-title":"Blood"},{"issue":"3","key":"2019111907353724200_B5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cancergencyto.2010.08.016","article-title":"CD5-positive, cyclinD1-negative mantle cell lymphoma with a translocation involving the CCND2 gene and the IGL locus.","volume":"204","author":"Shiller","year":"2011","journal-title":"Cancer Genet"},{"issue":"3","key":"2019111907353724200_B6","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood-2007-10-120824","article-title":"Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression.","volume":"111","author":"Herens","year":"2008","journal-title":"Blood"},{"issue":"11","key":"2019111907353724200_B7","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3324\/haematol.2009.010173","article-title":"Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR.","volume":"94","author":"Quintanilla-Martinez","year":"2009","journal-title":"Haematologica"},{"issue":"12","key":"2019111907353724200_B8","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1182\/blood-2007-10-118794","article-title":"Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas.","volume":"111","author":"Wlodarska","year":"2008","journal-title":"Blood"},{"issue":"9","key":"2019111907353724200_B9","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood.V98.9.2837","article-title":"Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies.","volume":"98","author":"Sonoki","year":"2001","journal-title":"Blood"},{"issue":"7","key":"2019111907353724200_B10","first-page":"2253","article-title":"Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma.","volume":"95","author":"Yatabe","year":"2000","journal-title":"Blood"},{"issue":"18","key":"2019111907353724200_B11","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2011-04-348367","article-title":"Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma.","volume":"118","author":"Griffiths","year":"2011","journal-title":"Blood"},{"issue":"11","key":"2019111907353724200_B12","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","article-title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype.","volume":"94","author":"Mozos","year":"2009","journal-title":"Haematologica"},{"issue":"3","key":"2019111907353724200_B13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/modpathol.2009.173","article-title":"Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes.","volume":"23","author":"Metcalf","year":"2010","journal-title":"Mod Pathol"},{"issue":"2","key":"2019111907353724200_B14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/PAS.0b013e318241f050","article-title":"Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.","volume":"36","author":"Zeng","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2019111907353724200_B15","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma.","volume":"70","author":"Fernandez","year":"2010","journal-title":"Cancer Res"},{"issue":"4","key":"2019111907353724200_B16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2559.2012.04260.x","article-title":"SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma.","volume":"61","author":"Hsiao","year":"2012","journal-title":"Histopathology"},{"issue":"2","key":"2019111907353724200_B17","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1182\/blood-2007-06-093401","article-title":"Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma.","volume":"111","author":"Ek","year":"2008","journal-title":"Blood"},{"issue":"11","key":"2019111907353724200_B18","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3324\/haematol.2009.008474","article-title":"Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma.","volume":"94","author":"Dictor","year":"2009","journal-title":"Haematologica"},{"issue":"2","key":"2019111907353724200_B19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3324\/haematol.2011.052621","article-title":"In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior.","volume":"97","author":"Carvajal-Cuenca","year":"2012","journal-title":"Haematologica"},{"issue":"1","key":"2019111907353724200_B20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0002-9440(10)64536-1","article-title":"Recurrent genetic aberrations in thymoma and thymic carcinoma.","volume":"157","author":"Zettl","year":"2000","journal-title":"Am J Pathol"},{"issue":"7","key":"2019111907353724200_B21","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1093\/nar\/gkp1215","article-title":"Waved aCGH: to smooth or not to smooth.","volume":"38","author":"Lepretre","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"2019111907353724200_B22","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1200\/JCO.2006.08.4251","article-title":"Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.","volume":"25","author":"Salaverria","year":"2007","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019111907353724200_B23","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/blood-2010-01-263806","article-title":"Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.","volume":"116","author":"Hartmann","year":"2010","journal-title":"Blood"},{"issue":"13","key":"2019111907353724200_B24","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1182\/blood-2008-07-170183","article-title":"Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling.","volume":"113","author":"Bea","year":"2009","journal-title":"Blood"},{"issue":"8","key":"2019111907353724200_B25","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/leu.2012.72","article-title":"Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease.","volume":"26","author":"Royo","year":"2012","journal-title":"Leukemia"},{"issue":"12","key":"2019111907353724200_B26","first-page":"4365","article-title":"Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants.","volume":"93","author":"Bea","year":"1999","journal-title":"Blood"},{"issue":"9","key":"2019111907353724200_B27","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma.","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"issue":"7354","key":"2019111907353724200_B28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"issue":"7418","key":"2019111907353724200_B29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"issue":"4","key":"2019111907353724200_B30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00439-009-0689-7","article-title":"Different molecular mechanisms causing 9p21 deletions in acute lymphoblastic leukemia of childhood.","volume":"126","author":"Novara","year":"2009","journal-title":"Hum Genet"},{"issue":"11","key":"2019111907353724200_B31","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/sj.leu.2403942","article-title":"A microRNA cluster as a target of genomic amplification in malignant lymphoma.","volume":"19","author":"Tagawa","year":"2005","journal-title":"Leukemia"},{"issue":"17","key":"2019111907353724200_B32","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1158\/0008-5472.CAN-09-1095","article-title":"MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas.","volume":"69","author":"Navarro","year":"2009","journal-title":"Cancer Res"},{"issue":"8","key":"2019111907353724200_B33","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.biocel.2010.03.004","article-title":"mir-17-92, a cluster of miRNAs in the midst of the cancer network.","volume":"42","author":"Olive","year":"2010","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/8\/1394\/1369068\/zh800813001394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/8\/1394\/1369068\/zh800813001394.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T12:35:58Z","timestamp":1574166958000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/8\/1394\/138824\/CCND2-rearrangements-are-the-most-frequent-genetic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,21]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,2,21]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-08-452284","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,21]]}}}